Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-102344
Filing Date
2016-05-16
Accepted
2016-05-16 13:54:17
Documents
52
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v439425_10q.htm 10-Q 480395
2 EXHIBIT 10.9 v439425_ex10-9.htm EX-10.9 14231
3 EXHIBIT 31.1 v439425_ex31-1.htm EX-31.1 10540
4 EXHIBIT 32.1 v439425_ex32-1.htm EX-32.1 4898
  Complete submission text file 0001144204-16-102344.txt   6080682

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ppch-20160331.xml EX-101.INS 903216
6 XBRL TAXONOMY EXTENSION SCHEMA ppch-20160331.xsd EX-101.SCH 65005
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ppch-20160331_cal.xml EX-101.CAL 33847
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ppch-20160331_def.xml EX-101.DEF 322825
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ppch-20160331_lab.xml EX-101.LAB 349309
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ppch-20160331_pre.xml EX-101.PRE 356001
Mailing Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124
Business Address PO BOX 114 CAMBERWELL, VICTORIA C3 3124 61 3 9208 4128
Propanc Health Group Corp (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 161652565
SIC: 2834 Pharmaceutical Preparations